Tag Results for "Pfizer"
Impact Reports
Mark
Little Mark is a small thin boy with huge brown eyes. He is pale and lethargic for a six-year-old. His mother, Rosie, is soft spoken and looks tired - with good reason. Her hands are full: both of her boys have hemophilia and Mark just recently had another bleed. Hemophilia causes a protein deficiency in the blood, which prevents… More
Case Studies
Pfizer & NCC Assist Underserved Patients
Pfizer partners with the National Cancer Coalition to provide medicine access to underserved patients in the developing world. Over the years, NCC and Pfizer have collaborated to provide significant donations in which thousands of patients with serious diseases like cancer, hemophilia, depression and other illnesses have received the therapies… More
Press Releases
NCC and Pfizer Partner to Provide 10 Million Units of Hemophilia Medicines
The National Cancer Coalition (NCC) is pleased to announce its recent collaboration with Pfizer, Inc to provide hemophilia medicines to underserved patients in the developing world. To date, NCC has received more than 10 million international units of ReFacto® Antihemophilic Factor (Recombinant), a therapy used for the treatment and prevention… More


